Cargando…

Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy

BACKGROUND: Considering the narrow immune response spectrum of a single epitope, and the nanoparticles (NPs) as a novel adjuvant can achieve efficient delivery of antigenic peptides safely, a nano-system (denoted as DSPE-PEG-Man@EM-NPs) based on cathepsin B-responsive antigenic peptides was designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wei, Qiu, Qianqian, Feng, Ziying, Tong, Zhenzhen, Guo, Weiwei, Zou, Feng, Yue, Na, Huang, Wenlong, Qian, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183215/
https://www.ncbi.nlm.nih.gov/pubmed/34083420
http://dx.doi.org/10.1136/jitc-2021-002523
_version_ 1783704338979356672
author Shi, Wei
Qiu, Qianqian
Feng, Ziying
Tong, Zhenzhen
Guo, Weiwei
Zou, Feng
Yue, Na
Huang, Wenlong
Qian, Hai
author_facet Shi, Wei
Qiu, Qianqian
Feng, Ziying
Tong, Zhenzhen
Guo, Weiwei
Zou, Feng
Yue, Na
Huang, Wenlong
Qian, Hai
author_sort Shi, Wei
collection PubMed
description BACKGROUND: Considering the narrow immune response spectrum of a single epitope, and the nanoparticles (NPs) as a novel adjuvant can achieve efficient delivery of antigenic peptides safely, a nano-system (denoted as DSPE-PEG-Man@EM-NPs) based on cathepsin B-responsive antigenic peptides was designed and synthesized. METHODS: Highly affinitive antigenic peptides were delivered by self-assembled NPs, and targeted erythrocyte membranes acted as a peptide carrier to improve antigenic peptides presentation and to strengthen cytotoxic T-cells reaction. Cathepsin B coupling could release antigenic peptides rapidly in dendritic cells. RESULTS: Evaluations showed that DSPE-PEG-Man@EM-NPs had obvious inhibitory effects towards both MCF-7 and MDA-MB-231 human breast cancer cell lines. CONCLUSION: Overall, this strategy provides a novel strategy for boosting cytotoxic T lymphocytes response, thereby expanding the adaptation range of tumor antigenic peptides and improving the therapeutic effect of tumor immunotherapy with nanomedicine.
format Online
Article
Text
id pubmed-8183215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81832152021-06-17 Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy Shi, Wei Qiu, Qianqian Feng, Ziying Tong, Zhenzhen Guo, Weiwei Zou, Feng Yue, Na Huang, Wenlong Qian, Hai J Immunother Cancer Basic Tumor Immunology BACKGROUND: Considering the narrow immune response spectrum of a single epitope, and the nanoparticles (NPs) as a novel adjuvant can achieve efficient delivery of antigenic peptides safely, a nano-system (denoted as DSPE-PEG-Man@EM-NPs) based on cathepsin B-responsive antigenic peptides was designed and synthesized. METHODS: Highly affinitive antigenic peptides were delivered by self-assembled NPs, and targeted erythrocyte membranes acted as a peptide carrier to improve antigenic peptides presentation and to strengthen cytotoxic T-cells reaction. Cathepsin B coupling could release antigenic peptides rapidly in dendritic cells. RESULTS: Evaluations showed that DSPE-PEG-Man@EM-NPs had obvious inhibitory effects towards both MCF-7 and MDA-MB-231 human breast cancer cell lines. CONCLUSION: Overall, this strategy provides a novel strategy for boosting cytotoxic T lymphocytes response, thereby expanding the adaptation range of tumor antigenic peptides and improving the therapeutic effect of tumor immunotherapy with nanomedicine. BMJ Publishing Group 2021-06-03 /pmc/articles/PMC8183215/ /pubmed/34083420 http://dx.doi.org/10.1136/jitc-2021-002523 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Basic Tumor Immunology
Shi, Wei
Qiu, Qianqian
Feng, Ziying
Tong, Zhenzhen
Guo, Weiwei
Zou, Feng
Yue, Na
Huang, Wenlong
Qian, Hai
Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
title Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
title_full Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
title_fullStr Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
title_full_unstemmed Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
title_short Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
title_sort design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
topic Basic Tumor Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183215/
https://www.ncbi.nlm.nih.gov/pubmed/34083420
http://dx.doi.org/10.1136/jitc-2021-002523
work_keys_str_mv AT shiwei designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT qiuqianqian designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT fengziying designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT tongzhenzhen designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT guoweiwei designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT zoufeng designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT yuena designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT huangwenlong designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy
AT qianhai designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy